Seeing Is Believing
Healthcare - Sector
CRSP is currently covered by 13 analysts with an average price target of $72.56. This is a potential upside of $20.21 (38.61%) from yesterday's end of day stock price of $52.35.
Crispr Therapeutics AG's activity chart (see below) currently has 420 price targets and 330 ratings on display. The stock rating distribution of CRSP is 88.46% BUY and 11.54% HOLD.
Analysts average stock forecasts to be materialized ratio is 65.46% with an average time for these price targets to be met of 105.32 days.
Highest price target for CRSP is $110, Lowest price target is $44, average price target is $72.56.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 31-Aug-2026. First documented stock forecast 14-Nov-2016.
Currently out of the existing stock ratings of CRSP, 23 are a BUY (88.46%), 3 are a HOLD (11.54%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2022
$82
$26.57 (47.93%)
$82
1 months 7 days ago
(31-Aug-2026)
9/30 (30%)
$25.02 (43.91%)
202
Buy Since 04-Mar-2021
$80
$24.57 (44.33%)
$80
1 months 7 days ago
(31-Aug-2026)
13/27 (48.15%)
$23.02 (40.40%)
167
Buy Since 18-Apr-2024
$88
$32.57 (58.76%)
$82
2 months 4 days ago
(04-Aug-2026)
12/23 (52.17%)
$34.93 (65.82%)
134
Buy Since 03-Feb-2025
$80
$24.57 (44.33%)
$80
3 months ago
(08-Jul-2026)
5/10 (50%)
$20.8 (35.14%)
82
Hold Since 11-Jun-2026
$60
$5.08 (9.25%)
$32
3 months 27 days ago
(11-Jun-2026)
8/9 (88.89%)
$9.77 (19.45%)
254
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst most recently updated their price target on CRSP (Crispr Therapeutics AG)?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?